Home Tags Colorectal cancer

Tag: colorectal cancer

Featured Image: Annual Congress of ESMO 2018. Courtesy: © 2018 European Society for Medical Oncology. Used with permission.

Encouraging Preliminary Results in Treatment of Colorectal Cancer with Trastuzumab Deruxtecan

Updated Phase I safety and efficacy data for [fam-] trastuzumab deruxtecan (DS-8201), an investigational HER2 targeting antibody-drug conjugate or ADC, were presented at the 2018 annual congress of the European Society for Medical Oncology - ESMO 2018, in Munich, Germany for a subgroup of patients with heavily pretreated HER2 expressing colorectal cancer.

Global Phase II Study of DS-8201 in Patients with HER2-Expressing Advanced...

Following initiation of pivotal phase II studies in HER2-positive breast cancer and gastric cancer, the initiation of a third phase II study in colorectal...

Merus Therpeutics: Seeking to Advance Immuno-Oncology

In Oncology, many new developments of the last decade have made it possible to treat cancers in ways that are better-targeted, more potent, and...

U.S. Food and Drug Administration Accepts Investigational New Drug Application for...

The U.S. Food and Drug Administration (FDA) has accepted the AbGenomics International's Investigational New Drug Application or IND for AbGn-107, the company's antibody-drug conjugate or ADC candidate...